Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Boehringer Ingelheim
Healthtrust
Fuji
Medtronic
Cantor Fitzgerald
Argus Health
Fish and Richardson

Generated: January 18, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: sumatriptan succinate; naproxen sodium

« Back to Dashboard

sumatriptan succinate; naproxen sodium Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan Pharms Inc sumatriptan succinate; naproxen sodium 090872 85MG; 500MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Healthtrust
Medtronic
US Army
Dow
Harvard Business School
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.